Navigation Links
Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
Date:6/11/2008

ST. LOUIS, June 11 /PRNewswire/ -- Orion Genomics announced today that the company entered into a worldwide exclusive license agreement with The Johns Hopkins University (JHU) to commercialize products that identify patients at risk for colorectal cancer. The license is based on a suite of issued and pending JHU patents covering imprinting abnormalities of the insulin-like growth factor 2 gene (IGF2). Orion's simple blood-based risk assessment test is being designed to identify people who carry the IGF2 biomarker and may be at increased risk of developing sporadic colorectal cancer. It is expected that the test will enable at-risk patients to undergo screening for colorectal cancer significantly earlier, allowing physicians to remove precancerous polyps and prevent future colon cancer.

Two published studies involving more than 200 patients have found that colorectal cancer and adenoma patients are at least five times more likely to carry the IGF2 biomarker than age-matched cancer-free patients serving as controls.

"We are pleased to obtain this exclusive license from The Johns Hopkins University to complete the development of our lead cancer risk assessment product and enter the market in the near future," said Nathan D. Lakey, President and CEO of Orion Genomics. "Our colorectal cancer risk test has the potential to save lives by identifying a group of high risk individuals who are likely to develop colorectal cancer at a younger age, and who should undergo colonoscopy screening 10 to 20 years earlier than the age that is currently recommended."

Loss of imprinting of IGF2 is a non-heritable epigenetic mutation detected in the blood of seven to 10 percent of the general population. Although epigenetic mutations do not affect the DNA sequence of a gene, cancer associated epigenetic changes can either turn off or "silence" genes that normally suppress cancer, or can inappropriately turn on genes that can lead to malignant cellular activity.
'/>"/>

SOURCE Orion Genomics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
2. Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
3. Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
4. Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Companys MicroRNA Technology
5. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
6. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. Grocery Manufacturers Association: Study Signals Progress in Battle Against Obesity
10. Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains
11. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...0 The National Association of Drug... new initiative in the war on methamphetamine. Th...ti-state electronic tracking program that enforces...dicines containing pseudoephedrine in real-time at...ased on a system that was developed and tested in ...
(Date:11/20/2009)... The Department of Heal...mbers of priority groups that did not have previou...cs are being held statewide on Nov. 20-22. Friday,...Saturday, Nov. 21, will be 8 a.m. to 2 p.m. On Sun... to 8 p.m. ,, Individuals in the recommended t...
(Date:11/20/2009)...Newswire/ -- Reportlinker.com announces that a new...gue. ,, Pipettes & Pipettors - A Global Ma...com/p0164373/Pipettes--Pipettors---A-Global-Market...dium=pr&utm_campaign=prnewswire ,, Pipett...f any research laboratory. Large-scale application...
Breaking Medicine Technology:National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12PEAK Surgical Announces First Use of PEAK PlasmaBlade 28TM 29 in Europe 48472 1PEAK Surgical Announces First Use of PEAK PlasmaBlade 28TM 29 in Europe 48472 2PEAK Surgical Announces First Use of PEAK PlasmaBlade 28TM 29 in Europe 48472 3PEAK Surgical Announces First Use of PEAK PlasmaBlade 28TM 29 in Europe 48472 4Bisphenol A exposure in pregnant mice permanently changes DNA of offspring 8788 1Bisphenol A exposure in pregnant mice permanently changes DNA of offspring 8788 2Helping Dad Stay Independent 3A The Best Fathers Day Gift for an Aging Parent A Checklist from Dr Dan Tobin Founder and CEO of Care Support of Ame 48467 1Helping Dad Stay Independent 3A The Best Fathers Day Gift for an Aging Parent A Checklist from Dr Dan Tobin Founder and CEO of Care Support of Ame 48467 2Helping Dad Stay Independent 3A The Best Fathers Day Gift for an Aging Parent A Checklist from Dr Dan Tobin Founder and CEO of Care Support of Ame 48467 3Helping Dad Stay Independent 3A The Best Fathers Day Gift for an Aging Parent A Checklist from Dr Dan Tobin Founder and CEO of Care Support of Ame 48467 4
..., BOULDER, Colo., Oct. 26 Tapestry,Pharmaceutica...to focus all,of its resources on advancing TPI 287...ls. As part of the strategic plan, Tapestry is red... expects to eliminate 14 positions,including execu...perations.,All clinical development staff remains ...
...Nasdaq: TELK ) reported positive preclinical data...olecule inhibitors of validated cancer targets,inc...esented today at the,AACR-NCI-EORTC Conference on ...rancisco. Aurora kinases are enzymes that play a ...er-expressed in many human cancers, including brea...
Other Medicine Technology:Tapestry Announces Strategy to Focus on TPI 287 Clinical Program 2Tapestry Announces Strategy to Focus on TPI 287 Clinical Program 3Tapestry Announces Strategy to Focus on TPI 287 Clinical Program 4Telik Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2 2
(Date:11/20/2009)... , , QUINCY, Mass., Nov. 20 /PRNewswire/ -...op Supermarket Company removed from sale Shedd,s C...ccoli Rice and Shedd,s Country Crock ® Side D...d sulfite allergen. ,, The following code date...ock ® Side Dishes DELUXE Cheddar Broccoli Ric...
(Date:11/20/2009)... , , MADISON, N.J., Nov. 20 /PRNewswire... influenza virus may have peaked in late October, ...tial source of illness in all age groups, includin...Diagnostics Incorporated (NYSE: DGX ), the world...tion and services. ,, In its most recent Quest...
(Date:11/20/2009)... , , ST. LOUIS, Nov. 20 /PRNewswire-Fir...day announced that it will present at the Bank of ...e held December 2-3, 2009, at the Crowne Plaza Hot...ll present Wednesday, December 2nd at 8:30 a.m. Ea... may access a live, audio webcast of Centene,s pre...
(Date:11/20/2009)... , , WINSTON-SALEM, N.C., Nov. 20 /PRNewsw...but he is on a mission to redefine what it means t...ofessional counselor with a specialty in family co... at Wake Forest University, Gladding says research...ten leads to sadness and even depression during th...
(Date:11/20/2009)... , , NEW YORK, Nov. 20 /PRNewswire-Fi...ay announced that it will broadcast Doctor Radio...mmograms , an in-depth special hosted by veteran j...ewscom.com/cgi-bin/prnh/20080819/NYTU044LOGO ) ,... to Know About Mammograms will air November 21 ...
Breaking Medicine News(10 mins):Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5
...mithKline Plc, Europe's pharmaceutical giant, is f...ntal// vaccine Cervarix against Merck & Co.'s Gard...cine against cervical cancer. The study, whi...pillomavirus. This virus is known to be the reason...
...ughed up along with phlegm could point to lung can... School of Medicine// who are developing an inexpe... early stage lung cancer in current and former smo...believed to be tumor suppressors are deleted in ce...
...ork is not welcome over Hong Kong anymore. Beginni...ster// coming from Mainland China will not be allo...ent at a hospital in the country. The move wa...9,538 in 2005. Hong Kong is favored when it com...
...rs, beware. Chlorinated pools have been added to t...tors.// Researchers from the Municipal Institu...with findings that discourage drinking, bathing wi... is Trihalomethanes (THM), by-products of chlorina...
...lds last as long as they do? - John Hopkins Resea...tion have found a clue to our bodies' defenses aga...ght in an effort not to go overboard and destroy h...Liu, Ph.D., professor of pharmacology, neuroscienc...
...ic drugs (opioids) are commonly prescribed for sho...ectiveness long-term has been questioned //in a re...cine, who also found that behaviors consistent wit...e used despite the concerns clinicians have with p...
Other Medicine News:Health News:Simple Test Detects Genetic Signs of Lung Cancer in a Patient’s Sputu 2Health News:Simple Test Detects Genetic Signs of Lung Cancer in a Patient’s Sputu 3Health News:Long-Term Narcotics Use for Back Pain May Be Ineffective and Lead to Abuse 2
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: